Kramer Kelly A. sold 3,800 shares of GILEAD SCIENCES, INC. at $169.44 for −$644k on Nov 12, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$643,880.74Shares × reported price
Shares traded
3,800Common Stock
Price per share
$169.44Reported price. Read footnotes for ranges.
% of reported position traded
37.85%This security and ownership context
Holdings after
6,239Direct
Trade date
Nov 12, 2026Sell
Filed
Nov 16, 2026, 3:32 PM ET4-day reporting delay
Accession
0001629885-26-000008Code S · Transaction 401792
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 10,039 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Option exercise10,376$66.92$694,361.92Trade 401790
Nov 12, 2026Option exercise10,376$0.00$0Trade 401795
Nov 12, 2026Sell1,676$168.23−$281,945.94Trade 401791
Nov 12, 2026Sell4,700$170.49−$801,322.27Trade 401793
Nov 12, 2026Sell200$171.44−$34,288Trade 401794
6 transaction rows in this filing. Joint filers share the same rows.

GILD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GILD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −12%1w ago 0%1d ago +1.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2026. F2: Sale prices for the transactions reported range from $167.95 to $168.88. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3: Sale prices for the transactions reported range from $169.04 to $169.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4: Sale prices for the transactions reported range from $170.08 to $171.01. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5: 25% of the shares subject to the option vested on each three-month anniversary measured from May 10, 2017 such that 100% of the shares subject to the option were fully vested and exercisable on May 10, 2018.